ETHYL 2-(5-BROMO-3-NITROPYRIDIN-2-YL)ACETATE, 95.0%, 250mg

3-Methylcinnamic Acid>98.0%(T)25g

2-(methoxymethyl)-6-methylpyridine, 95%, 250mg

(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-yl (2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoate, 98%, 5g

Ethyl 3-Cyclopentene-1-carboxylate>97.0%(GC)25g

6-(Pyrrolidin-1-yl)pyridin-2-amine, 250mg

5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[c][1,2,5]thiadiazole, 97%, 5g

7-Chloro-2-methyl-3-(5-methylpyridin-2-yl)quinazolin-4(3H)-one, 5mg

2,5-dimethoxy-4-methylbenzenesulfonyl chloride, 95.0%, 5g

p-(Octyloxyphenyl)phenyliodonium hexafluor antimonate, 25g

5-Bromo-2-chloronicotinamide, 95.0%, 250mg

2,8-Bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)dibenzo[b,d]furan, 95%, 100mg

3-Bromo-1,1,1-trifluoroacetone, 97.0%, 500g